• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Xsolis Launches Next Gen AI-Powered Platform; Saves MultiCare Health $8M

by Fred Pennic 09/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Xsolis, an AI-driven technology company, today announced the official launch of Dragonfly®, a groundbreaking AI platform designed to streamline administrative tasks, reduce avoidable denials, and enhance collaboration between healthcare providers and payers. 

– The launch coincides with Xsolis’ annual conference, XCHANGE ’24, where healthcare leaders will gather to discuss the future of the industry.

Dragonfly®: Driving Efficiencies and Improving Patient Care

Dragonfly is a next-generation AI-powered platform that leverages clinical and financial data from electronic medical records (EMRs) to create real-time patient profiles. This enables the generation of highly precise predictive analytics, helping determine the most suitable level and setting of care for each patient.

MultiCare Health System, a prominent healthcare provider in Washington State, has already experienced significant benefits from Dragonfly. By utilizing its AI insights, they have cut case review times by up to 50%, improving operational efficiency and patient care management.

“Xsolis’ AI technologies enable our clinicians to work more efficiently and accurately while bringing our payers to the table as partners for better decision-making, which has saved MultiCare more than $8 million in just the past year,” said Debbie Schardt, assistant vice president of revenue cycle and utilization management with MultiCare Health System. “Dragonfly elevates our user experience by reducing administrative tasks, ensuring more appropriate reimbursement and increased compliance, while reducing avoidable denials.” 

Dragonfly Key Features and Benefits:

  • Generative AI: Supports nurses and caregivers by automating redundant tasks.
  • Enhanced Collaboration: Facilitates interoperability and data sharing between the platform and other systems, fostering deeper collaboration among healthcare stakeholders.
  • AI-Driven Length of Stay Management: Optimizes patient throughput and resource allocation.

Xsolis: Pioneering AI in Healthcare

Since 2013, Xsolis has been at the forefront of applying AI in healthcare, empowering clients to make informed decisions regarding medical necessity and patient throughput. Their proprietary Care Level Score™, used by over 500 hospitals nationwide, utilizes predictive analytics and machine learning to identify cases requiring immediate attention. To date, Xsolis has generated over 2.7 billion predictions, leading to significant improvements in level of care authorizations, length-of-stay management, and avoidable denial reduction.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |